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Abstract: BACKGROUND COVID-19 is a novel coronavirus infection that can cause a severe respiratory
illness and has been declared a pandemic by the World Health Organization (WHO). Because children
appear to be less severely affected than adults, their imaging appearances have not been extensively
reported. OBJECTIVE To systematically review available literature regarding imaging findings in paedi-
atric cases of COVID-19. MATERIALS AND METHODS We searched four databases (Medline, Embase,
Cochrane, Google Scholar) for articles describing imaging findings in children with COVID-19. We in-
cluded all modalities, age <18 years, and foreign language articles, using descriptive statistics to identify
patterns and locations of imaging findings, and their association with outcomes. RESULTS Twenty-two
articles were included, reporting chest imaging findings in 431 children, of whom 421 (97.7%) underwent
CT. Criteria for imaging were lacking. At diagnosis, 143/421 (34.0%) had a normal CT. Abnormalities
were more common in the lower lobes and were predominantly unilateral. The most common imaging
pattern was ground-glass opacification (159/255, 62.4%). None of the studies described lymphadenopa-
thy, while pleural effusions were rare (three cases). Improvement at follow-up CT imaging (3-15 days
later) was seen in 29/100 (29%), remained normal in 25/100 (25%) and progressed in 9/100 (9%). CON-
CLUSION CT chest findings in children with COVID-19 are frequently normal or mild. Lower lobes are
predominantly affected by patchy ground-glass opacification. Appearances at follow-up remain normal
or improve in the majority of children. Chest CT imaging adds little to the further management of the
patient and should be reserved for severe cases or for identifying alternative diagnoses.
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Abstract
Background COVID-19 is a novel coronavirus infection that can cause a severe respiratory illness and has been declared a
pandemic by the World Health Organization (WHO). Because children appear to be less severely affected than adults, their
imaging appearances have not been extensively reported.
Objective To systematically review available literature regarding imaging findings in paediatric cases of COVID-19.
Materials and methods We searched four databases (Medline, Embase, Cochrane, Google Scholar) for articles describing
imaging findings in children with COVID-19. We included all modalities, age <18 years, and foreign language articles, using
descriptive statistics to identify patterns and locations of imaging findings, and their association with outcomes.
Results Twenty-two articles were included, reporting chest imaging findings in 431 children, of whom 421 (97.7%) underwent
CT. Criteria for imaging were lacking. At diagnosis, 143/421 (34.0%) had a normal CT. Abnormalities were more common in the
lower lobes and were predominantly unilateral. The most common imaging pattern was ground-glass opacification (159/255,
62.4%). None of the studies described lymphadenopathy, while pleural effusions were rare (three cases). Improvement at follow-
up CT imaging (3–15 days later) was seen in 29/100 (29%), remained normal in 25/100 (25%) and progressed in 9/100 (9%).
Conclusion CT chest findings in children with COVID-19 are frequently normal or mild. Lower lobes are predominantly affected by
patchy ground-glass opacification. Appearances at follow-up remain normal or improve in the majority of children. Chest CT imaging
adds little to the further management of the patient and should be reserved for severe cases or for identifying alternative diagnoses.
Keywords Adolescents .Children .Computedtomography .Coronavirus .COVID-19 .Imaging .Radiology .Systematicreview
Introduction
A novel strain of coronavirus (referred to as 2019-nCoV or
SARS-CoV-2), which causes the sometimes severe
respiratory infection COVID-19, was first identified in
Wuhan city, China, toward the end of 2019 [1]. By 12
March 2020, COVID-19 was declared a global pandemic by
the World Health Organization (WHO), and at the time of
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writing it had spread to 187 countries, with almost 3.5 million
confirmed cases, and had claimedmore than 244,000 lives [2].
Epidemiological studies originating from China have
shown that children are less likely to be clinically affected
than older adults, with one study finding only 0.9% of those
affected being younger than 15 years old [3]. A different
Chinese study, which included 731 confirmed paediatric
cases, found that the majority (84.1%) sustained either mild
or moderate symptoms, with <3% described as being severely
or critically affected [4]. Only one study reported a death in a
child, a 10-month-old with multiorgan failure and intussus-
ception [5]. In the United States, data published on 2 April
2020 [6] showed that only 1.7% (n=2,572) of people affected
by COVID-19 were younger than 18 years, with 0.58–2% of
children requiring intensive care admission. Given the low
number of paediatric cases, keeping abreast of the latest infor-
mation and assimilating the combined knowledge of radio-
graphic findings in infected children is challenging. Whilst
several systematic reviews of imaging findings in COVID-
19 cases have been performed for adults [7, 8], none has
specifically focused on children.
The overall objective of this study was therefore to assim-
ilate the available information on imaging features of COVID-
19 disease in children. Particular points of interest include
identifying typical imaging findings during diagnosis and
follow-up stages of the infection, and whether any features
might be used as prognostic markers to determine patient out-
come. Where knowledge gaps exist, we intend to highlight
these and suggest potential future avenues for research.
Materials and methods
Ethics approval was not required for this retrospective review
of published data. We followed Preferred Reporting Items for
Systematic reviews and Meta-Analyses (PRISMA) guidelines
for transparent reporting of systematic reviews. This study
was registered in PROSPERO, an international prospective
regis ter of systemat ic reviews (Regist rat ion ID:
CRD42020175945 [9]).
Literature review
A systematic literature search was performed of Medline
(Ovid), Embase and the Cochrane Library databases for the
latest articles published between 1 January 2015 and 17
March 2020 (5-year range), using database-specific Boolean
search strategies with key terms and word variations relating
to all three categories:
(1) “coronavirus”, “COVID-19”, “SARS-CoV-2” or “2019-
nCoV”;
(2) “paediatrics”, “children”, “neonate”, “infant” or
“adolescent”;
(3) “radiology”, “imaging”, “ultrasound”, “CT”, “MRI” or
“radiography.”
Full search terms are shown in the supplementary material
(Tables S1, S2 and S3). To include as many recent articles as
possible, we also performed a grey literature search (i.e. liter-
ature not formally published in sources such as books or jour-
nal articles [10], such as government white paper articles and
guidelines) using the same keywords on Google Scholar and
for any WHO Global Library publications. Additional articles
were retrieved by manual screening of the reference lists of
included studies and relevant review articles/editorial pieces.
The initial search was conducted on 17 March 2020. A repeat
search was conducted on 23 March 2020, and again on 30
April 2020 for any further eligible manuscripts.
Eligibility criteria
Inclusion criteria encompassed all studies investigating and
describing imaging findings of confirmed COVID-19 infec-
tion in children, using reverse transcriptase polymerase chain
reaction (RT-PCR) testing. Studies were limited to human
subjects, including foetuses (any gestation) and children (ages
0–18 years). No restrictions were placed on type of imaging
modality, number of cases described or type of clinical setting.
To widen our search and include as many cases as possible,
we included case reports. No language restrictions were used
given that many early articles on imaging findings have been
published in Chinese. Where this was the case, we sought
online translation services and advice from native-speaking
colleagues to interpret reported findings.
Exclusion criteria included studies reported as editorials,
opinion articles or multimedia files (online videos, podcasts).
Suspected but unconfirmed cases of COVID-19 were not in-
cluded. Studies relating to other coronavirus-related illnesses,
such as Middle East respiratory syndrome (MERS) or severe
acute respiratory syndrome (SARS) were excluded. We also
excluded any articles reporting on a mixed adult and paediat-
ric cohort where imaging results for the paediatric cohort
could not be extracted.
Data extraction and quantitative data synthesis
All articles were independently searched by two reviewers
(S.C.S. and S.T. with 7 years and 10 years of paediatric radi-
ology experience, respectively). They examined abstracts of
suitable studies and obtained full papers according to the eli-
gibility criteria. Disagreements were resolved by consensus.
The same two reviewers (S.C.S., S.T.) independently ex-
tracted data from the full articles into a database (Excel;
Microsoft, Redmond, WA), which included the following
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factors: study design, study setting/country, population demo-
graphics (e.g., gender, age, underlying comorbidities), sample
size, patient outcomes (number of mortalities), imaging mo-
dality and imaging findings (pattern and location of involve-
ment of disease) and results of any follow-up imaging.
Missing data were recorded as “not recorded” or “not stat-
ed”. Authors of published studies were not contacted because
of the tight time constraints involved in the completion of the
systematic review during the unprecedented time of need for
this information.
Methodological quality
The quality for each included study was assessed using the
National Institutes of Health Quality Assessment Tool for
Case Series Studies [11] by two reviewers (S.T. and J.L, with
17 years of paediatric radiology experience). Disagreements
were resolved by consensus review. Any that could not be
resolved by consensus was arbitrated by a third reviewer
(S.C.S.).
Statistical analysis
We planned a meta-analysis to assess association of imaging
findings with patient outcomes and demographic data; how-
ever, we omitted this because of a lack of sufficient data, with
many cases being incompletely reported. Therefore, we used
descriptive statistics to determine frequency and percentages
of imaging appearances across different articles.
Results
Included studies
During the initial literature search, after removing duplicates,
we identified 146 unique records. After screening titles and
abstracts, we excluded 100 studies and checked 46 full-text
articles. Reasons for exclusions included insufficient descrip-
tion regarding imaging results (n=8), opinion pieces (n=7),
adult population only (n=5), no confirmed (only suspected)
COVID-19 cases (n=3), retracted article (n=2) and no full text
available (n=1). After the second and third searches of the
databases, we found eight more records that met our inclusion
criteria and reviewed them.
Although it was not explicitly stated in the articles, we
found that a small case series of 8 children [12] and a
larger one of 115 children [13] appeared to describe a
subset of a larger case series already published of 171
children with COVID-19 [5] (included in our review).
All three articles originated from Wuhan city, China.
We therefore excluded the two smaller studies from fur-
ther qualitative or quantitative analysis. We have provided
the reference and summary results from the smaller arti-
cles in our supplementary appendix (Tables S4 and S5; [5,
12–34]) to alert readers to this overlap and show why we
reached this conclusion.
Methodological quality
Most articles were given an overall scoring of “fair” (17/26,
65.4%), with 5/26 (19.2%) described as “good”. Four of 26
(15.4%) articles were scored as “poor”; these were excluded
from further analysis, mainly for poor descriptions of radio-
graphic findings in non-representative cohorts [35–38].
Methodological quality assessment of the studies is presented
in Table 1 [5, 13–22, 24–34, 36–38].
We therefore analysed 22 studies overall in this systematic
review (19 case series, 3 case reports), including 431 children
with imaging (241 male, or 55.9%) [5, 12, 14, 15, 17–34, 39].
Two (2/22, 9.1%) articles were in Chinese [18, 34], the re-
mainder in English. All articles were published in 2020, over a
4-month period from January to April.
Patient demographics
The demographics of the children and their presenting com-
plaints are summarised in Table 2 [5, 14–34] and expanded
upon in the supplementary material (Table S4). All children
were confirmed COVID-19 cases on RT-PCR testing. The
studies mainly originated from China (20/22, 91.0%), with
1/22 (4.5%) from South Korea [25] and 1/22 (4.5%) from
Iran [29]. Of the Chinese studies, 4/22 (18.2%) described
cases from Wuhan city [5, 23, 27, 28]. The youngest child
in our cohort was 36 h old; the oldest was 17 years old.
Ninety-eight (98/431, 22.7%) children were asymptomatic
upon admission to hospital, being assessed for having recent
travel to a COVID-19 endemic area or close contact with an
infected individual. Of those with symptoms, fever (120/333,
36.0%) and coughing (139/333, 41.7%) were the more com-
mon presenting complaints.
Imaging modality and parameters
The majority of the imaging modalities described in the stud-
ies were chest CT (21/22, 95.5%), of which only 1/21 (4.8%)
utilised intravenous contrast agent for imaging [25]. In one
study (1/22, 4.5%) only chest radiography findings were de-
scribed [14]. In 5/22 (22.7%) studies, a combination of both
chest radiography and CT imaging findings were described
[25–27, 29, 32]. None of the studies described MRI, nuclear
medicine or chest ultrasound findings (see supplementary ma-
terial for full details, Table S5 [5, 12–34]).
In only 5/22 (22.7%) studies were the CT vendor and scan-
ner model described [18, 22, 23, 28, 34]. Of these, four articles
provided detailed imaging acquisition parameters [18, 22, 28,
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Table 1 Quality ratings of included studies according to the National Institutes of Health (NIH) Quality Assessment Tool for Case Series Studies [11]
Author [reference] Questiona Final consensus
Reviewer 1 2 3 4 5 6 7 8 9 Overall rating
Cai J et al. [14] 1 N Y N CD NA Y CD NA Y Fair Fair
2 Y Y Y NA N Y CD Y Y Fair
Chan JF et al. [15] 1 Y Y NR CD NA Y CD NA Y Fair Fair
2 Y Y Y Y N Y CD Y Y Fair
Chen C et al. [16] 1 Y Y NR NA N Y N Y Y Fair Fair
2 Y Y Y CD N Y CD Y Y Fair
Chen F et al. [35] 1 N NA NA NA N Y CD NA N Fair Poor
2 N Y NA NA N NA CD NA Y Poor
Cui Y et al. [17] 1 Y NA NA CD Y Y Y NA Y Good Good
2 Y Y NA CD Y NA Y NA Y Good
Feng K et al. [18] 1 Y Y NR CD Y Y Y N Y Fair Fair
2 Y Y CD CD Y Y CD N Y Fair
Hu Z et al. [19] 1 Y Y NR CD N Y Y Y Y Fair Fair
2 Y Y CD Y N Y Y Y Y Good
Ji LN et al. [20] 1 Y Y NR CD N Y CD NA Y Fair Fair
2 Y Y NA CD N Y CD NA Y Good
Li W et al. [21] 1 Y Y NR CD N Y Y NA Y Fair Fair
2 Y Y CD CD N Y Y NA Y Good
Liu H et al. [22] 1 Y Y NR Y Y Y N Y Y Good Good
2 Y Y CD CD Y Y CD Y Y Good
Liu M et al. [31] 1 Y N NR CD N Y CD NA Y Fair Fair
2 Y Y NR Y Y N Y NA N Poor
Lu X et al. [5] 1 Y Y NR CD N Y N N Y Fair Fair
2 Y Y CD CD N Y CD N Y Good
Ma H et al. [23] 1 Y Y NR CD Y Y Y Y Y Good Good
2 Y Y CD CD Y Y Y Y Y Good
Pan X et al. [24] 1 N Y NA CD N NA N NA Y Fair Fair
2 N Y Y Y N Y Y NA Y Fair
Park JY et al. [25] 1 Y NA NA NA N Y N NA Y Fair Fair
2 Y NA NA NA N Y Y NA Y Fair
Qiu H et al. [30] 1 Y Y Y NA N Y CD Y Y Fair Fair
2 N Y NR Y Y Y NR NA N Poor
Rahimzadeh G et al. [29] 1 N Y NR CD Y Y Y N Y Fair Fair
2 Y Y CD CD N Y CD N Y Fair
Shen Q et al. [32] 1 Y Y NA Y Y Y Y NA Y Fair Fair
2 Y Y NR Y Y Y Y NA Y Fair
Tang A et al. [26] 1 Y Y NR CD N Y CD Y Y Fair Fair
2 Y Y CD CD N Y CD Y Y Fair
Wang D et al. [36] 1 Y Y NR CD N Y CD N N Fair Poor
2 Y N CD CD N N CD N N Poor
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34]. One study did not report on the CT scanner model but did
report upon the imaging parameters [17]. Details on imaging
protocols and parameters are provided in the supplementary
material, Table S6 [5, 15–34]. In only 10/22 (45.5%) articles
was a radiologist identified as a co-author. Detailed indica-
tions for performing CT imaging were lacking in all studies.
Initial imaging findings
Where CT imaging was used, 143/421 (34.0%) cases did not
have any radiographic findings despite being COVID-19 pos-
itive. In the one study where only chest radiography was used,
6/10 (60%) of the imaged cases were normal [14]. In a case
report from South Korea, the admission chest radiography
was normal, although the CT demonstrated patchy nodular
consolidation with ground-glass opacification [25].
Throughout all studies, there was significant heterogeneity
in terminologies used with reference to radiographic findings,
many of which included well-known terms (e.g., ground-glass
opacifications) as well as non-standard descriptive terminolo-
gies (e.g., “thickened lung texture” [27]). In addition, missing
information regarding imaging findings made summarising
these difficult. Despite this, available findings are summated
Tables 3 and 4 [5, 14–34]. It should be acknowledged that the
percentage of cases for the various descriptors is less impor-
tant than their relative frequencies to one another, given the
missing information.
From the reports where location of pathology was stated,
this was identified in the upper lobe in 31/90 (34.4%), middle
lobe in 15/90 (16.7%) and the lower lobe of the lung in 40/90
(44.4%) children. Diffuse/multifocal disease was described in
4 patients (4.4%).
Pathology was unilateral in 78/146 (53.4%) and bilateral in
68/146 (46.6%) children. Subpleural disease (i.e. peripheral in
location) was specifically described in 13 cases across three
studies [19, 25, 26].
Where a specific pattern was described, the most charac-
teristic pattern on CT was ground-glass opacity, reported in
159/255 (62.3%) children. Patchy consolidations were seen in
14/255 (5.5%) patients. A so-called halo sign (of ground-glass
opacification) around areas of consolidation was reported in
24/255 (9.4%) children across four studies [18, 28, 29, 34].
Nonspecific terminologies of “lung infiltrates/shadows” were
reported in 111/255 (43.5%) and interstitial lesions in 5/255
(1.9%) children. Not all articles had case-specific individual
descriptions of chest radiography and CT findings, which
were frequently described together.
Several findings were either not reported or only rarely
reported. For example, none of the articles described signifi-
cant mediastinal lymphadenopathy or cavitation on imaging,
although only one study performed a contrast-enhanced CT.
In only 3/255 (1.2%) children there were pleural effusions. Of
these, one was a neonate also infected with respiratory
Table 1 (continued)
Author [reference] Questiona Final consensus
Reviewer 1 2 3 4 5 6 7 8 9 Overall rating
Wang S et al. [27] 1 Y NA NA NA N Y Y NA Y Good Good
2 Y NA NA NA N NA Y NA Y Good
Xia W et al. [28] 1 Y Y NR CD Y Y Y N Y Good Good
2 Y Y Y CD Y Y CD N Y Good
Zeng LK et al. [37] 1 N NA NA NA N Y CD NA N Fair Poor
2 N NA NA NA N Y CD NA N Poor
Zhang Y et al. [38] 1 N NA NA NA N Y Y NA N Poor Poor
2 N Y NA NA N Y CD NA N Poor
Zheng F et al. [33] 1 N Y Y Y Y Y N NA Y Fair Fair
2 N Y Y Y Y Y N Y Y Fair
Zhou Y et al. [34] 1 Y Y NR NA Y Y Y NA Y Fair Fair
2 Y Y NR Y Y Y Y NA N Fair
CD cannot determine, N no, NA not applicable, NR not reported, Y yes
aThe NIH Quality Assessment Tool for Case Series Studies questions include the following nine questions: (1) Was the study question or objective
clearly stated?; (2) Was the study population clearly and fully described, including a case definition?; (3) Were the cases consecutive?; (4) Were the
subjects comparable?; (5)Was the intervention (i.e. imagingmodality) clearly described?; (6)Were the outcomemeasures clearly defined, valid, reliable,
and implemented consistently across all study participants?; (7)Was the length of follow-up adequate?; (8)Were the statistical methods well-described?;
and (9) Were the results well-described?
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Initial imaging timinga Initial imaging findingsb
Cai J et al. [14] 10 CXR Admission 6 (60%) normal
4 (40%) unilateral patchy infiltrates
(1 retrocardiac opacity, left lung; 3 right lung
opacification)
Chan JF et al. [15] 1 Chest CT NS CT showed GGO (location and laterality not mentioned)
Chen C et al. [16] 31 Chest CT Admission 20 (64.5%) normal
8 (25.8%) unilateral pneumonia
3 (9.7%) bilateral pneumonia
Example imaging in 4 cases all demonstrated patchy
peripheral GGO in middle or lower lobes
Cui Y et al. [17] 1 Chest CT Admission (Day 6 post symptoms) Mild perihilar GGO in RUL and RLL
Feng K et al. [18] 15 Chest CT Admission 6 (40%) normal
9 (60) inflammatory infiltrations — patchy nodular,
GGO, visible halo sign (4 in single lobar segment;
4 in at least two lobar segments; 1 in more than
two lobar segments)
Hu Z et al. [19] 6 Chest CT Admission 4 (66.7%) normal
1 (16.7%) right basal subpleural ground-glass
opacification
1 (16.7%) ground-glass opacification/patchy shadowing
Ji LN et al. [20] 2 Chest CT NS 2 (100%) normal
Li W et al. [21] 5 Chest CT 4 days post admission
(range 2–9 days)
2 (40%) normal
3 (60%) patchy GGO
(2 LLL, 1 RUL)
Liu H et al. [22] 4 Chest CT NS, presumed on admission 1 (25%) normal
1 (25%) single area of consolidative change, RLL
1 (25%) single area of GGO, RML
1 (25%) multifocal consolidation + pleural effusion
Liu M et al. [31] 5 Chest CT Admission 1 (20%) normal
2 (40%) unilateral GGO
1 (204%) unilateral GGO and consolidation
1 (20%) bilateral GGO
Lu X et al. [5] 171 Chest CT NS 60 (35%) none
56 (32.7%) ground-glass opacification
32 (18.7%) local patchy shadowing
21 (12.3%) bilateral patchy shadowing
2 (1.2%) interstitial abnormalities
Ma H et al. [23] 50 Chest CT NS, presumed on admission 29 (67%) ground-glass opacities
16 (37%) localized patchy shadowing
9 (21%) bilateral patchy shadows
3 (7%) interstitial lesions
1 (2%) pleural effusion
Lesion location
28 (65%) lower lobe
9 (18%) middle lobe
22 (44%) upper lobe
Pan X et al. [24] 1 Chest CT 1 day post admission Normal
Park JY et al. [25] 1 CXR
Chest CT
Admission CXR and CT CXR: normal
CT: patchy, nodular consolidations with peripheral GGO
in subpleural areas of RLL
Qiu H et al. [30] 36 Chest CT NS 17 (47%) normal
19 (53%) GGO








CT not specified, presumed upon
admission also
CXR
2 (66.7%) ‘airspace shadowing’ (location not specified)




syncytial virus (RSV) [22]. The underlying conditions of the
other cases were not reported [23].
Follow-up imaging findings
In 11/22 (50%) studies, repeat CT imaging results were de-
scribed, representing a total of 100 children. The CT was
performed 3–15 days after admission, with a quarter of imag-
ing studies remaining normal (25/100, 25%) or showing some
improvement from previously detected abnormalities (29/100,
29%). In a minority of cases the abnormalities had progressed
(9/100, 9%) or new findings developed (4/100, 4%). Findings
were stable in 18/100 (18%) cases, and a complete resolution
of previous abnormalities was seen in 15/100 (15%) (Table 5)
[16–19, 21–23, 27, 28, 31, 34]. For one study where only







Initial imaging timinga Initial imaging findingsb
2 (66.7%) patchy consolidation with halo sign,
and GGO in both lungs
1 (33.3%) normal
Shen Q et al. [32] 9 CXR
Chest CT
NS— both modalities reported together
in report
7 (77.8%) normal
2 (22.2%) unilateral GGO
Tang A et al. [26] 26 CXR
Chest CT
NS 11 (42%) lateral pulmonary infiltrates
7 (27%) bilateral pulmonary infiltrates
Wang S et al. [27] 1 CXR
Chest CT
CXR at Day 2 post admission
CT at Day 4 post admission
Initial CXR showed thickened lung texture
Initial CT showed high-density nodular shadow
at posterior segment of LUL
Xia W et al. [28] 20 Chest CT NS, presumed on admission 4 (20%) normal
6 (30%) unilateral pulmonary lesion
10 (50%) bilateral lung lesions
Of these,
16 (80%) subpleural ground-glass opacities
10 (50%) central consolidation with surrounding
ground-glass halo
12 (60%) ground-glass opacities
4 (20%) fine mesh shadow
3 (15%) micronodules




NS, presumed on admission 8 (33%) normal
5 (21%) unilateral findings
11 (46%) bilateral findings
Number of cases with different pattern of abnormalities
not stated, although typical findings of bilateral
patchy shadows or consolidations were mentioned
Zhou Y et al. [34] 9 Chest CT CT within 3 days of admission Pattern
1 (11.1%) normal (incidental bullae noted in LLL)
8 (88.9%) inflammatory changes (6 GGO with
consolidation;
1 consolidation only; 1 GGO only)
1 (11.1%) pleural effusion





6 (75%) upper lobe
6 (75%) lower lobe
5 (62.5%) middle lobe
a Initial timing of imaging might be days since onset of symptoms or days since admission to hospital
b Imaging patterns described are as written in the publications
CT computed tomography, CXR chest radiography,GGO ground-glass opacification, LLL left lower lobe, LUL left upper lobe, NC non-contrast, NS not
stated, RLL right lower lobe, RML right middle lobe, RT-PCR reverse transcriptase polymerase chain reaction, RUL right upper lobe, US ultrasound
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Imaging findings and demographics
Given the small number of cases and the heterogeneous nature
of case reporting, we could not to determine whether differ-
ences in imaging presentations varied significantly with pa-
tient age group, gender or presenting symptoms.
Given the lack of available RT-PCR testing kits in many
countries, there has been interest in using CT to identify early
pulmonary findings suggestive of COVID-19, particularly
where children are asymptomatic but at risk of disease
because of infected co-habitants. In a subset of 30 children
across 10 publications, we extracted imaging findings from
asymptomatic children (Table S7) [5, 15, 16, 18, 19, 21,
23–27, 30–32, 34]. Of these, 11/30 (36.7%) had normal CT
findings, 14/30 (46.7%) reported the more typical pattern of
ground-glass opacification and 4/30 (13.3%) described non-
specific, consolidative changes, or “patchy shadowing”.
Regarding differences with adults, Ma et al. [23] found that
children in their cohort (compared to a published adult cohort
of 1,099 cases [3]), were more likely to demonstrate





Abnormalities Lobe affected Laterality Segments Subpleural






Unilateral Bilateral One Two
Cai J et al. [14] 10 CXR 6 4 4
Chan JF et al. [15] 1 Chest CT 0 1
Chen C et al. [16] 31 Chest CT 20 11 8 3
Cui Y et al. [17] 1 Chest CT 0 1 1 1 1
Feng K et al. [18] 15 Chest CT 6 9 1 4 4
Hu Z et al. [19] 6 Chest CT 4 2 1 1 1
Ji LN et al. [20] 2 Chest CT 2 0
Li W et al. [21] 5 Chest CT 2 3 1 2
Liu H et al. [22] 4 Chest CT 1 3 1 1 1
Liu M et al. [31] 5 Chest CT 1 4 3 1
Lu X et al. [5] 171 Chest CT 60 111 32 21
Ma H et al. [23] 50 Chest CT 0 50 22 9 28 9
Pan X et al. [24] 1 Chest CT 1 0
Park JY et al. [25] 1 CXR
Chest CT
0 1 1 1 1





1 2 2 2
Shen Q et al. [32] 9 CXR
Chest CT
7 2 2
Tang A et al. [26] 26 CXR
Chest CT
8 18 11 7 11
Wang S et al. [27] 1 CXR
Chest CT
0 1 1
Xia W et al. [28] 20 Chest CT 4 16 6 10
Zheng F et al. [33] 25
(24 had
CT)
Chest CT 8 16 5 11
Zhou Y et al. [34] 9 Chest CT 1 8 6 5 6 4 4

















The findings correspond to readily available reported imaging findings within the relevant publications. Only COVID-19 confirmed cases by reverse
transcriptase polymerase chain reaction (RT-PCR) are included. Because of the heterogeneous and occasionally incomplete reporting of these findings
(e.g., some without pathology location, some using different terminologies), not all features are mutually exclusive, nor total to the combined number of
patients; therefore, percentages are not provided for features that were only reported by a small number of publications (e.g., segmental involvement and
subpleural distribution), and the denominator for lobe affected and laterality is derived for total number of studies where these findings were stated
CT computed tomography, CXR chest radiograph, LL lower lobe, ML middle lobe, UL upper lobe
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abnormalities on chest CT (86% [43/50] vs. 76% [840/
1,099]), although these were less likely to be bilateral (18%
[9/50] vs. 46% [505/1,099]) and less likely to demonstrate
interstitial abnormalities (6% [3/50] vs. 13% [143/1,099]).
The presence of ground-glass opacification (58% [29/50] vs.
50% [550/1,099]) and local patchy “shadowing” (32% [16/
50] vs. 37% [409/1,099]) was similar between children and
adults.
Patient outcomes
At time of publication, 296/431 (68.7%) children had been
discharged from the hospital, 72/431 (16.7%) were in a stable
condition in a hospital, 3/431 (0.7%) had been admitted to
intensive care units. One child admitted to intensive care re-
portedly later died at 4 weeks post hospital admission; this
was a 10-month-old with multiorgan failure, septic shock
and intussusception [5]. The outcome of the remainder of
cases was unclear from the published reports (60/431, 13.9%).
One study performed subgroup analysis to determine the
relationship between patient outcomes and CT imaging results
[23]. The authors reviewed a subset of 23/50 (46.0%) children
in their cohort who had been discharged, whose symptoms had
resolved andwho had negative RT-PCR testing on two separate
occasions. The majority of these children 17/23 (73.9%) still
demonstrated lung abnormalities, and in 2 cases these had
progressed. A Cox regression analysis did not find any statisti-
cally significant association between differences in imaging
findings during treatment and likelihood of discharge. This
was supported in part by findings by Xia et al. [28], who stated
that CT findings appeared to lag behind resolution of clinical
symptoms and two sets of negative nucleic acid testing.
Discussion
Chest CT imaging findings in children with COVID-19 are
frequently normal or mild, with lower lobes most commonly


















Chan JF et al. [15] 1 1 1
Chen C et al. [16] 11 4 4
Cui Y et al. [17] 1 1 1
Feng K et al. [18] 9 9 9 9 9
Hu Z et al. [19] 2 2 2 1
Li W et al. [21] 3 3 3
Liu H et al. [22] 3 3 1 2 1
Liu M et al. [31] 4 4 4 1
Lu X et al. [5] 111 111 56 53 2
Ma H et al. [23] 50 50 29 25 3 1
Park JY et al. [25] 1 1 1 1
Qiu H et al. [30] 19 19 19
Rahimzadeh G et al. [29] 2 2 2 2 2
Shen Q et al. [32] 2 2 2
Tang A et al. [26] 18 18 18
Wang S et al. [27] 1 1 1 1
Xia W et al. [28] 16 16 16 1 10 4 3
Zhou Y et al. [34] 8 8 8 7 3 1














Descriptors refer to those stated within the relevant publications. Because of the heterogeneous, non-standard terminologies, we included descriptions of
“shadows/infiltrates” together and interpret these to mean nonspecific opacities. In many articles, there was incomplete reporting of findings; therefore,
not all features are mutually exclusive, nor total to the combined number of children within the study. The column titled “pattern described” is therefore
included to demonstrate how many of the reported abnormal CT cases for which the study provided the abnormalities. The relative frequencies of
findings are provided (with the “total pattern described” as denominator, rather than total abnormal CT), which is the more important indicator than the
absolute numbers summated
CT computed tomography, GGO ground-glass opacification
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affected, demonstrating patchy ground-glass opacification or,
less frequently, areas of consolidation. Imaging appearances at
follow-up remain normal or improve in the majority of
children.
These findings raise important clinical implications for
paediatricians and radiologists. Given the mild and some-
times absent findings on chest radiography and CT, it is
unlikely that imaging will provide an increased confidence
in the diagnosis for COVID-19, nor can it provide reassur-
ance for the absence of infection if imaging is normal. This
finding is supported by a recent study of 24 asymptomatic
carriers of COVID-19, of whom 6 were children (5–
15 years old) and all had normal chest CT findings [19].
Similar results have also been supported by work in adults
[40, 41]. Whilst it is well known that chest radiography can
underplay the chest CT findings, the identification of mild
to moderately severe imaging appearances in the majority
of children, with little subsequent change in management,
is unlikely to justify the CT imaging.
Conversely, even when CT findings are present, we have
found that these can be heterogeneous and nonspecific, and in
the adult literature it has been reported that differentiation
between COVID-19 and other viral infections based on imag-
ing findings is difficult [42]. Research on this topic in paedi-
atric radiology is currently unavailable, although Qiu et al.
[30] compared clinical findings between children with
COVID-19, H1N1 influenza and severe acute respiratory syn-
drome (SARS) and found that children with COVID-19 had a
much milder course of illness than with SARS, but were more
likely to develop pneumonia than those with H1N1 influenza.
Future studies that focus on attempting to differentiate imag-
ing findings among these viral illnesses in children should be
mindful to account for co-existing viral infections given that
one publication in this study demonstrated COVID-19 in a
child with co-infection of RSV [22].
In recent publications, it has been shown that some paedi-
atric patients might be “super spreaders” (i.e. high viral shed-
ding) [43] and more likely to demonstrate early symptoms.
Whether they also display earlier CT changes, which could
be used to screen for individuals prior to available RT-PCR
testing, remains unknown. Therefore, given the lower severity
of disease and additional radiation burden, CT imaging should
not be routinely conducted for diagnosis, but rather reserved
for those with severe or deteriorating symptoms, or in the
search for an alternative diagnosis to aid management.
The fact that imaging appearances frequently resolve, im-
prove or remain normal at follow-up imaging is reassuring
because it suggests that long-term pulmonary damage is un-
likely, although at present there is insufficient evidence to
confirm this. It is also important to bear in mind that the
persistence of pulmonary findings does not necessarily imply
ongoing infection, given that one study found persisting CT
findings in 17/23 (73.9%) children who had been treated, with
resolution of their symptoms and two negative RT-PCR tests.
Therefore, follow-up CT imaging would also be better guided
by clinical symptoms rather than being performed as a matter
of routine. These recommendations have recently been incor-
porated into newly published guidelines for imaging in
Table 5 Follow-up CT imaging findings in children with COVID-19





















Chen C et al. [16] 28 NS 19 7 1 1
Cui Y et al. [17] 1 11 1
Feng K et al. [18] 15 3–5 3 2 7 3
Hu Z et al. [19] 1 13 1
Li W et al. [21] 3 5–7 3
Liu H et al. [22] 3 7 1 2
Liu M et al. [31] 5 4–14 1 4
Ma H et al. [23] 29 NS 2 17 2 8
Wang S et al. [27] 1 15 1
Xia W et al. [28] 6 NS 2 4
Zhou Y et al. [34] 8 3–5 (n=7)
10 (n=1)
1 1 4 2
Total 100 3–15 25 (25%) 15 (15%) 29 (29%) 18 (18%) 4 (4%) 9 (9%)
Only articles detailing follow-up CT imaging are included in this table. The fzindings correspond to readily available reported findings within the
relevant publications
CT computed tomography, NS not stated
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children with COVID-19 by the Radiological Society of
North America (RSNA) [44], which encourages a pragmatic
approach based on patient symptom severity using chest radi-
ography for initial workup and only for follow-up in moderate
to severe cases, reserving an initial chest CT only where a
clinical change in management is anticipated and for the
post-recovery stages. Useful advice regarding general staff
protection and departmental organisation for imaging of
COVID-19 cases has also been recently provided by the
European Societies of Radiology (ESR) and Thoracic
Imaging (ESTI) [45].
It is worth noting that although our inclusion criteria were
not set to review infected pregnant women, there was one case
in this review of an infected newborn, diagnosed at 36 h of age
from a COVID-19-positive mother [27]. The authors pro-
posed the possibility for vertical transmission as a route of
infection; however, several subsequent articles reviewing out-
comes of infected pregnant women have now suggested this to
be unlikely [39, 46–48]. A recently published rapid review of
coronavirus in pregnancy [49] found that of the 32 infected
women identified in the literature, there was 1 stillbirth
(34 weeks of gestation) and 15/32 (47%) pre-term deliveries.
In the 15/32 (47%) neonates who were tested for COVID-19,
all were negative. The latest guidance from the Royal College
of Obstetricians and Gynaecologists [50] has therefore recom-
mended against routine separation of affected mothers and
their babies and has not found any evidence to suggest intra-
uterine fetal infection or teratogenic effects from the novel
coronavirus. Clinicians should thus remain alert to alternative,
more common diagnoses in newborns presenting with respi-
ratory symptoms (e.g., respiratory distress syndrome, aspira-
tion, pneumonia from alternative organisms), even if the
mother is COVID-19 positive [48].
Although we performed a comprehensive systematic re-
view, there are still several gaps in our radiologic knowledge
regarding COVID-19 in children. In this article we included
manuscripts relating to radiographic or CT appearances of
lung pathologies in children, although information on other
modalities is lacking. There is sparse literature on the use of
portable point-of-care ultrasound (POCUS) for adult COVID-
19 patients in Italy [51] and in children [52, 53]. In adults,
POCUS has been reportedly used to triage more severe cases
for urgent management by helping to identify areas of ground-
glass opacification (so-called B lines) as well as areas of ne-
crotic lung— a marker of the more advanced stages of infec-
tion [54]. Nevertheless, given that severe disease in children is
less likely, the extent to which POCUS might be helpful is
questionable, although it has been recommended as one of
several potential options for lung assessment by a Chinese
expert consensus review for neonatal management in
COVID-19 [55]. Two adult publications have reported the
use of [F-18]2-fluoro-2-deoxyglucose (FDG) positron emis-
sion tomography (PET)/CT in COVID-19 [56, 57], and
suggested that it could help monitor disease progression and
treatment outcomes, particularly by detecting residual activity
in mediastinal lymph nodes. This modality has not been re-
ported in infected children, and adult studies have only includ-
ed a small number of cases (4 patients or fewer). The added
value is thus still undetermined [58] and should not be first
studied in children, particularly given the increased radiation
burden.
Our review also did not find many articles reporting imaging
findings in immunocompromised children, so it is undetermined
whether these features might differ from those without health
conditions. It has been well documented that more severe infec-
tions are found in immunocompromised children with other
strains of coronavirus [59] and that these infections can spread
to other parts of the body, such as the brain, causing encephalitis
[60]. Whether this also occurs with COVID-19 remains to be
seen. It is interesting that the only child death reported in this
review was also suffering from an intussusception. Whether this
was triggered by the underlying viral infection is unclear, but it is
worth noting that gastrointestinal complaints can be the first and
more prominent symptom of COVID-19 in some people and has
been reported in an adult series [61].
There are several limitations to this work. Given the wide-
spread public health interest, several manuscripts on the topic
of COVID-19 are emerging each week, many bypassing usual
peer review processes. It is likely that some information might
be missing but later included, or in certain cases articles
retracted (as for two articles during our screening process).
Nevertheless, where possible, we have tried to mitigate this
by conducting our literature review thrice in order to provide
the most up-to-date information from reliable sources. Whilst
not all imaging findings in all cases were reported in the stud-
ies, we described all available findings to give a general over-
view of the imaging pathology. Future works on the study of
COVID-19 imaging findings could be improved by the use of
standardised detailed descriptors for imaging findings (i.e.
stating both the pattern and localisation of findings), in line
with RSNA guidance [44], with clearly stated indications for
imaging where possible.
Second, because of the origin of the virus in China, some
articles have been published in a language other than English,
or in English by non-native speakers. This might have ham-
pered our understanding and interpretation of the data, al-
though we used online translation services where required.
Whilst other systematic reviews on the topic of COVID-19
have excluded articles not written in English, we thought it
was important to review as many foreign-language articles
where possible to increase our collective knowledge base,
particularly given the few reported paediatric cases.
Finally, the majority of articles have included children from
China, in particular Wuhan city. It is unclear whether some of
these paediatric cohorts overlap, although we did identify three
papers where there was clear similarity in many of the patients
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described, and we avoided repetition of findings in summary
results. It is also important to highlight that differences in indi-
cations for CT imaging in children might also exist (which
could explain why Ma et al. [23] found slightly more abnor-
malities on CT in children than adults), but unfortunately these
indications were not made clear in the publications.
Conclusion
Chest imaging findings in children with COVID-19 are fre-
quently normal or mild, with unilateral changes that include
patchy ground-glass opacification, commonly affecting the
lower lobes. Imaging appearances at follow-up frequently re-
main normal or improve in the majority of children. Chest CT
imaging adds little to the further management of the child and
should be reserved for severe cases or for identifying alterna-
tive diagnoses. Further areas of research should include infor-
mation on imaging and clinical characteristics in immuno-
compromised children with COVID-19, and information on
long-term follow-up, particularly in the more severely affected
children. We should therefore be prudent with the usage of
CT, particularly at a time where resources are stretched, and
only use it in the more vulnerable populations.
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